18th International Congress on Infectious Diseases

1-4 March 2018
Buenos Aires, Argentina 

In collaboration with the XVIII Congreso de la Sociedad Argentina de Infectología (SADI, the Infectious Diseases Society of Argentina), the event’s objective is to cover all of the fields of infectious diseases with particular attention to the major challenges of the region, with both regional and international expertise. DNDi is a co-operating organization of the event.


Opening Ceremony

Date: Thursday, 1 March 2018
Time: 18:30 – 20:00

Long-Term Zika Complications
Vanessa Van der Linden Mota, Association for Assistance of Disabled Children, Brazil

Advances and Challenges in the Treatment of Chagas Disease – a Global Perspective
Sergio Sosa-Estani, Head of Chagas, DNDi Latin America, Argentina
Enteric Infections in Under Resourced Countries – From Research to Clinical Practice
Gagandeep Kang, Executive Director, Translational Health Science & Technology, India
The Human Microbiome
David Relman, Thomas C. and Joan M. Merigan Professor in Medicine, Microbiology & Immunology, Stanford University, USA
Emerging Infectious Diseases – The Next Pandemic
George Fu Gao, Professor and Director in CAS Key Laboratory of Pathogenic Microbiology and Immunology, Chinese Academy of Sciences, China


Parallel Symposium

New Outbreaks of Cutaneous Leishmaniasis and Management
In collaboration with DNDi

Date: Friday, 2 March 2018
Time: 17:00 – 18:00
Venue:  Libertador A

Cutaneous Leishmaniasis Outbreaks and Management
Oscar Salomón, Director, National Institute of Tropical Medicine, Argentina

Cutaneous Leishmaniasis: Treatment Needs and Combination Therapies
Byron Arana, Head of Cutaneous Leishmaniasis, DNDi, Switzerland


Parallel Symposium

Alternative Strategies to Deliver Affordable Treatment for Hepatitis C Patients
In collaboration with DNDi

Date: Saturday, 3 March 2018
Time: 15:15 – 16:45
Venue:  Libertador B

HCV – Global Challenges
Marcelo Silva, Head of Hepatology and Liver Transplant Unit, Austral University Hospital, Argentina

Affordable Treatment Approaches for HCV with Sofosbuvir plus Ravidasvir Combination
Graciela Diap, Paediatric HIV/HCV, DNDi, Switzerland
Addressing IP Barriers To The Elimination of HCV As A Public Health Problem in Latin America
Francisco Viegas Neves da Silva, Regional Policy Advocacy Consultant, DNDi Latin America, Brazil



More information: